Peptides, Oligonucleotides, Carbohydrates and Synthetic Lipids

Peptides, Oligonucleotides, Carbohydrates and Synthetic Lipids

You can get quick access to a number of our services by making just one phone call.

Offering access to a wide range of products, including conjugates, to meet customer needs, including:

  • Fully integrated service offering > from APIs to finished dosage and pharmaceutical services (clinical trial kits preparation, randomization and logistics).
  • Backward integration for key starting materials > securing the supply chain in terms of costs & quality.
  • Multiple manufacturing locations across Europe & the USA offering flexibility of supply.

Peptides, Oligonucleotides, Lipids & Carbohydrates Platform is comprised of Bio-organic APIs & Excipients (Oligonucleotides, Peptides, Lipids & Carbohydrates). Our experts manufacture Peptide APIs using solid-phase, solution-phase, and hybrid solid-solution phase technology at all scales. The wide range of down-stream processing capabilities, including preparative HPLC purification at any scale, benefits oligonucleotide manufacturing at any stage of development. Also, capabilities extend to well-known f expertise in synthetic Lipid and Carbohydrate manufacturing. To complete the fully integrated service offering, while supporting customers with Fill & Finish and Pharma Packaging / Logistic services (clinical trial kits, randomization & logistics).

With streamlined process development, scale-up and large-scale manufacture, Peptide expertise is supported by three cGMP peptide API facilities: In addition to the GMP facility process development teams and to increase the R&D throughput.

Other platform capabilities include:

  • Pegylated Peptides
  • GLP-1 Peptides & Long Peptide Sequences
  • Cyclic Peptides; Peptides with multiple (up to 4) disulfide bridges
  • Fatty Acid & Carbohydrate Conjugated Peptides
  • Arginine-rich Peptides
  • Peptide Mimetic Synthesis
  • Short Peptides (up to 12 residues), often with no preparative HPLC purification

20 Years

Of experience serving the drug discovery market.

$100 Million

In transactions between pharmaceutical companies and our global supplier base.

200+

Biotech programs brokered to date.

Ready to see how we can help you hit your R&D goals?

Please don’t hesitate to reach out to us today to discuss how we can help you reach your objectives.

WBENC

Drug Discovery Alliances was recently certified by the Greater Womens Council and received the Women’s Business Enterprise National Council certification.

HUB Zone certification

Drug Discovery Alliances was recently HUB Zone Certified.